Fundraising Fox
Orexigen Therapeutics
La Jolla, US · Founded 2019 · Delaware corporation · 146 employees on LinkedIn · 6 known investors
Find your way into Orexigen Therapeutics
Sign up to see every warm intro you have to Orexigen Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orexigen Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases. The company works within the healthcare and pharmaceutical industry to address patient health challenges.
Founders & leadership
Board
Investors · 6
How we know: Cross Creek Advisors's portfolio page · Not right? Tell us
How we know: Montreux Equity Partners's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$274.6M disclosed across 3 rounds · 2015–2017
▶$49.6MraisedMar 2017 · 9 investors · PharmaceuticalsRule 506(b)
- Deborah JornDirector
- Thomas LynchExecutive Officer
- Jason KeyesExecutive Officer
- David J EndicottDirector
- Patrick J MahaffyDirector
- Thomas CannellExecutive Officer
- Louis C BockDirector
- Peter K HonigDirector
- Peter FlynnExecutive Officer
- Brian H. DoveyDirector
- Michael NarachiExecutive Officer, Director
- Lota S ZothDirector
- Offering amount
- $49.6M
- Amount sold
- $49.6M
- Sales commissions
- $1.6M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$165MraisedMar 2016 · 21 investors · PharmaceuticalsRule 506(b)
- Louis C BockDirector
- Eckard WeberDirector
- Michael NarachiExecutive Officer, Director
- Lota S ZothDirector
- Thomas CannellExecutive Officer
- Preston KlassenExecutive Officer
- David J EndicottDirector
- Thomas LynchExecutive Officer
- Brian H. DoveyDirector
- Patrick J MahaffyDirector
- Heather AceExecutive Officer
- Peter K HonigDirector
- Offering amount
- $330M
- Amount sold
- $165M
- Sales commissions
- $5M
- Placement agents
- Leerink Partners LLC
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60MraisedSep 2015 · 1 investors · PharmaceuticalsRule 506(b)
- Preston KlassenExecutive Officer
- Joseph HaganExecutive Officer
- Eckard WeberDirector
- Brian H. DoveyDirector
- Louis C BockDirector
- Patrick J MahaffyDirector
- Lota S ZothDirector
- Peter K HonigDirector
- Michael NarachiExecutive Officer, Director
- Wendy L DixonDirector
- David J EndicottDirector
- Thomas CannellExecutive Officer
- Offering amount
- $90M
- Amount sold
- $60M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Orexigen Therapeutics went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Orexigen Therapeutics.
Frequently asked questions
- What does Orexigen Therapeutics do?
- Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases. The company works within the healthcare and pharmaceutical industry to address patient health challenges.
- Who are Orexigen Therapeutics's investors?
- Orexigen Therapeutics's investors include Cross Creek Advisors, Montreux Equity Partners, New Enterprise Associates (NEA), Sofinnova Ventures, Domain Associates, Domain Partners.
- How much funding has Orexigen Therapeutics raised?
- Orexigen Therapeutics has disclosed $274.6M raised across 3 rounds.
- Where is Orexigen Therapeutics headquartered?
- Orexigen Therapeutics is headquartered in La Jolla, US.